secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viewbix Inc. (QXL)
CIK:        0000797542
Form:       8-K
Filed at:   2026-05-14T20:15:48+00:00
Accession:  0001493152-26-023096
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quantum X Labs files audited financials of acquired Quantum Israel; going concern cited
--------------------------------------------------------------------------------

- Quantum Israel had $0 revenue, net loss of $273k for Jan-Dec 2025; total assets $448k, cash $260k.
- Auditor's report includes going-concern emphasis: losses since incorporation, negative operating cash flow.
- Key asset: exclusive license from Tel Aviv University for quantum error correction technology.
- Company holds equity stakes in CliniQuantum (48%), Quantum Transportation (30%), Quantum Gyro (40%).
- Acquisition closed March 4, 2026; consideration includes shares and warrants representing 40% of issuer's capital plus milestone shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/797542/000149315226023096/0001493152-26-023096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/797542/000149315226023096/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-023096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer